Quick Answer
Sanara MedTech Inc. reported Revenue (ASC 606) of $103.12 million for fiscal year 2025.
Sanara MedTech Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $103.12M | +19.0% |
| 2024 | $86.67M | +33.4% |
| 2023 | $64.99M | +41.8% |
| 2022 | $45.84M | +89.9% |
| 2021 | $24.14M | +54.9% |
| 2020 | $15.59M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.33M | +21.5% | +1.9% |
| June 30, 2025 | $25.83M | +28.1% | +10.2% |
| March 31, 2025 | $23.43M | +26.4% | +8.1% |
| September 30, 2024 | $21.67M | +35.2% | +7.5% |
| June 30, 2024 | $20.16M | +28.0% | +8.8% |
| March 31, 2024 | $18.54M | +19.4% | +15.7% |
| September 30, 2023 | $16.02M | +22.8% | +1.7% |
| June 30, 2023 | $15.75M | +62.9% | +1.5% |
- Sanara MedTech Inc. showed an increase of +19.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2020–2025 period, Sanara MedTech Inc.’s revenue (asc 606) has grown by 561.6% (from $15.59 million to $103.12 million).
- The most recent figure is from Sanara MedTech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: